Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-012652

CHIEF OPERATING OFFICER sold 4,875 shares at $22.72 ($110,769)

  • CHIEF OPERATING OFFICER acquired 4,875 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-06 Exercise or conversion : show line 1 in the form 10b5-1 +4,875 $2.48 $12,090 4,875 D
2024-05-06 Sale : show line 2 in the form 10b5-1 −4,875 $22.72 $110,769 0 D
Open-market sales · 4,875 sh · avg $22.72 · $110,769

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-06 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −4,875 55,842 D
Loading xslF345X05/form4-05092024_120559.xml…